[1] Perlroth J,Choi B,Spellberg B.Nosocomial fungal infections:epidemiology,diagnosis,and treatment[J].Med Mycol,2007,45(4):321-346.
[2] Nucci M,Anaissie E.Revisiting the source of candidemia:skin or gut[J]? Clin Infect Dis,2001,15;33(12):1959-1967.
[3] Wiesner SM1,Jechorek RP,Garni RM,et al.Gastrointestional colonization by Candida albicans mutant strains in antibiotic-treated mice[J].Clin Diagn Lab Immunol,2001,8(1):192-195.
[4] Yordanov M,Dimitrova P,Patkar S,et al.Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections[J].J Med Microbiol,2005,54,647-653.
[5] White SJ,Rosenbach A,Lephart P,et al.Self-regulation of Candida albicans population size during GI colonization[J].PLoS Pathog,2007,3(12):e184.
[6] Maraki S,Lionakis S,Ntaoukakis M,et al.Effects of levofloxacin,moxifloxacin and prulifloxacin on murine gut colonization by Candida al-bicans[J].Med Mycol,2011,49(4):419-423.
[7] Vautier S,Drummond RA,Redelinghuys P,et al.Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract[J].Infect Immun,2012,80(12):4216-4222.
[8] Cutler JE,Corti M,Lambert P,et al.Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus[J].PLoS One,2011,6(7):e22030.
[9] Vautier S,Drummond RA,Chen K,et al.Candida albicans colonization and dissemination from the murine gastrointestinal tract:the influence of morphology and Th17 immunity[J].Cell Microbiol,2015,17(4):445-450.
[10] Wenji Song,Huafeng Wang,Jiangye Chen.Candida albicans Sfl2,a temperature-induced transcriptional regulator,is required for virulence in a murine gastrointestinal infection model[J].FEMS Yeast Res,2011,11(2):209-222.
[11] Mellado E,Cuenca-Estrella M,Regadera J,et al.Sustained gastrointestinal colonization and systemic dissemination by Candida albicans,Candida tropicalis and Candida parapsilosis in adult mice[J].Diagn Microbiol Infect Dis,2000,38(1):21-28.
[12] Takahashi K,Kita E,Konishi M,et al.Translocation model of Candida albicans in DBA-2/J mice with protein calorie malnutrition mimics hematogenous candidasis in humans[J].Microb Pathog,2003,35(5):179-187.
[13] Clemons KV,Stevens DA.Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-gamma[J].Med Mycol,2000,38(3):213-219.
[14] Clemons KV,Stevens DA.Efficacy of ravuconazole in treatment of mucosal candidosis in SCID mice[J].Antimicrob Agents Chemother,2001,45(12):3433-3436.
[15] Ashman RB,Vijayan D,Wells CA.IL-12 and related cytokines:function and regulatory implications in Candida albicans infection[J].Clin Dev Immunol,2011,2011:686597.
[16] Westwater C,Schofield DA,Nicholas PJ,et al.Candida glabrata and Candida albicans;dissimilar tissue tropism and infectivity in a gnotobiotic model of mucosal candidiasis[J].FEMS Immunol Med Microbiol,2007,51(1):134-139.
[17] Westwater C,Balish E,Warner TF,et al.Susceptibility of gnotobiotic transgenic mice (Tgepsilon26) with combined deficiencies in natural killer cells and T cells to wild-type and hyphal signalling-defective mutants of Candida albicans[J].J Med Microbiol,2007,56(Pt 9):1138-1144.
[18] Schofield DA,Westwater C,Balish E.Divergent chemokine,cytokine and beta-defensin responses to gastric candidiasis in immunocompetent C57BL/6and BALB/c mice[J].J Med Microbiol,2005,54(Pt 1):87-92.
[19] Clemons KV,Gonzalez GM,Singh G,et al.Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs[J].Antimicrob Agents Chemother,2006,50(8):2650-2657.
[20] Koh AY,Köhler JR,Coggshall KT,et al.Mucosal damage and neutropenia are required for Candida albicans dissemination[J].PLoS Pathog.2008,8;4(2):e35.
[21] Kretschmar M,Felk A,Staib P,et al.Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice[J].Microb Pathog,2002,32(2):61-70.
[22] Nichterlein T,Buchheidt D,Hein A Comparison of glucan detection and galactomannan enzyme immunoassay in gastrointestinal and systemic murine candidiasis.Diagn Microbiol Infect Dis,2003,46(2):103-108.
[23] Fan D,Coughlin LA,Neubauer MM,et al.Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization[J].Nat Med,2015,21(7):808-814.
[24] Uno K,Sugiura S,Konishi M,et al.Evaluation of diagnostic methods for Candida albicans translocation in a mouse model:seminested polymerase chain reaction,blood culture,and serological assays[J].J Infect Chemother,2007,13(4):196-203.
[25] Lei Yan,Chunhui Yang,jianguo Tang.Discruption of the intestinal mucosal barrier in Candida albicans infections[J].Microbiological Reseach,2013,168(7):389-395.
[26] Andrew Y.Koh.Murine model of Candida gastrointestinal colonization and dissemination[J].Eukaryot Cell,2013,12(11):1416-1422.
[27] Yamaguchi N,Sonoyama K,Kikuchi H,et al.Gastric colonization of Candida albicans differs in mice fed commercial and purified diets[J].J Nutr,2005,135(1):109-115.
[28] Nagi M,Tanabe K,Takano Y,et al.Serum or bile affects the in vitro azole susceptibilities of Candida spp[J].Jpn J Infect Dis,2009,62(4):306-308.
[29] Jacobsen ID,Lüttich A,Kurzai O,et al.In vivo imaging of disseminated murine Candida albicans infection reveals unexpected host sites of fungalpersistence during antifungal therapy[J].J Antimicrob Chemother,2014,69(10):2785-2796.
[30] Conti HR,Huppler AR,Whibley N,et al.Animal models for candidasis[J].Curr Protoc Immunol,2014,(105)105:19.6.1-19.6.17.
[31] Rahman D,Mistry M,Thavaraj S,et al.Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions[J].Microbes Infect,2007,9(5):615-622.